Satellite Banner
Technology Networks Header
Friday, October 24, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Fight Against Illegal Poaching and Trafficking
Tuesday, April 22, 2014
FLUIDX joins the Smithsonian project in endangered species.

National Institute of Animal Biotechnology Adopts DNASTAR Software
Thursday, April 17, 2014
NIAB chooses DNA software as its primary sequence assembly and analysis software platform.

Molecular Devices to Attend Fourth Annual European Lab Automation (ELA) 2014
Wednesday, April 16, 2014
Molecular Devices® will be showcasing the next generation SpectraMax® MiniMax™ 300 imaging cytometer.

Sartorius Launches New Lab Balance on the Market
Wednesday, April 16, 2014
Quintix® is a user-friendly, highly accurate standard laboratory balance, redefining the meaning of easy for standard lab applications.

Cancer Researcher Wins Cytation™ 3 in BioTek's Contest!
Saturday, April 12, 2014
Dr. Jeff Peterson wins Cytation™ 3 cell imaging multi-mode reader in "Think Possible" Application Contest.

Immunovaccine's DepoVax™ Technology Underpins New Experimental Therapy for Cancers
Wednesday, April 09, 2014
IMV vaccine adjuvant technology of choice for Dana-Farber's HPV-related cancer clinical trial.

Life Technologies Releases New Research Tool
Tuesday, April 08, 2014
Oncomine NGS RNA-Seq Gene Expression Browser extends the Oncomine NGS Power Tools product offering.

Horizon Launches New GENASSIST CRISPR and rAAV Gene Editing Tools and Services
Tuesday, April 08, 2014
Comprehensive product and service solution enables easier, robust implementation of gene editing experiments in customer’s hands.

Bio-Rad’s Droplet Digital™ PCR Technology Highlighted at the 2014 AACR Annual Meeting
Tuesday, April 08, 2014
Introduced less than three years ago, ddPCR is rapidly gaining acceptance within the cancer research community. In fact, from 2012 to 2013, the number of cancer research papers involving ddPCR has nearly quintupled.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 2529
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv